Browsing by Author Rivory, Laurent

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 31  next >
Issue DateTitleAuthor(s)Citation
2006Altered deoxyuridine and thymidine in plasma following capecitabine treatment in colorectal cancer patients.Clarke, Stephen; Li, Kong; Rivory, Laurent; Sharma, Rohini; Hoskins, Janelle M.; Concord Clinical School: ANZAC Research Institute; School of Medical Sciences: Pharmacology; Central Clinical School: Medicine; Western Clinical School: Westmead Millennium InstituteAltered deoxyuridine and thymidine in plasma following capecitabine treatment in colorectal cancer patients., British Journal of Clinical Pharmacology, vol.63,(1),2006,pp 67-74
2003Baseline Nutritional Assessment in Advanced Cancer Patients Receiving Palliative ChemotherapyCharles (nee Slaviero), Kellie; Clarke, Stephen; Read, Jane; Rivory, Laurent; School of Medical Sciences: Pharmacology; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: MedicineBaseline Nutritional Assessment in Advanced Cancer Patients Receiving Palliative Chemotherapy, Nutrition and Cancer: an international journal, vol.46,(2),2003,pp 148-157
2003Carbon monoxide disposition and permeability-surface area product in the foetal circulation of the perfused term human placentaLe Couteur, David; McLean, Anthony; Peek, Michael; Rivory, Laurent; Sangalli, Michel; Concord Clinical School: ANZAC Research Institute; Nepean Clinical School: Medicine; Nepean Clinical School: Obstetrics & Gynaecology; Central Clinical School: Medicine; Medicine Faculty OfficeCarbon monoxide disposition and permeability-surface area product in the foetal circulation of the perfused term human placenta, Placenta, vol.24,(1),2003,pp 8-11
2004Effect Of Short-Term Morphine Exposure On P-Glycoprotein Expression And Activity In Cancer Cell Lines.Bebawy, Mary; Hoskins, Janelle; Pajic, Marina; Rivory, Laurent; Roufogalis, Basil; Pharmacy; School of Medical Sciences: Pharmacology; School of Medical Sciences: Pharmacology; Central Clinical School: Medicine; PharmacyEffect Of Short-Term Morphine Exposure On P-Glycoprotein Expression And Activity In Cancer Cell Lines., Oncology reports, vol.11,(5),2004,pp 1091-1095
2004Factors Affecting Cytochrome P-450 3A Activity In Cancer Patients.Charles, Janice; Clarke, Simon; Rivory, Laurent; Sparreboom, Alex; Baker, Sharyn D; Carducci, Michael A; Dawkins, Fitzroy; Dinh, Kimberly; Gelderblom, Hans; Graveland, Wilfried J; McGuire, William P; Schenk, Paul W; Sparreboom, Alex; Ten Tije, Albert J; Van Schaik, Ron H N; Verweij, Jaap; School of Public Health: Public Health; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Medicine; Concord Clinical School: Age & Alzh Dis Rrch EducFactors Affecting Cytochrome P-450 3A Activity In Cancer Patients., Clinical Cancer Research, vol.10,(12),2004,pp 8341-8350
2002Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase responseCharles (nee Slaviero), Kellie; Clarke, Stephen; Rivory, Laurent; School of Medical Sciences: Pharmacology; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineHepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response, British Journal of Cancer, vol.87, 3,pp 277-280
2005The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance.Hilmer, Sarah; Le Couteur, David; Rivory, Laurent; Fraser, Robin; McLean, Allan J; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineThe hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance., Clinical Pharmacokinetics, vol.44,(2),2005,pp 187-200
2005Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer.Balleine, Rosemary; Clarke, Christine; Farlow, David; Gurney, Howard; Mann, Graham; Rivory, Laurent; Wong, Mark; Evans, Scott; Hoskins, Janelle M.; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Imaging; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: Medicine; Western Clinical School: Westmead Millennium InstituteHepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer., Clinical Pharmacology & Therapeutics, vol.77,(1),2005,pp 33-42
2007Imatinib Disposition and ABCB1 (MDR1, P-Glycoprotein) GenotypeBalleine, Rosemary; Clarke, Christine; Gurney, Howard; Hoskins, Janelle; Mann, Graham; McLachlan, Andrew; Rivory, Laurent; Wilcken, Nicholas; Wong, Mark; Collins, Michael; Delforce, S-E; Lynch, Kevin; Schran, H.; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); School of Medical Sciences: Pharmacology; Western Clinical School: Westmead Millennium Institute; Pharmacy; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium InstituteImatinib Disposition and ABCB1 (MDR1, P-Glycoprotein) Genotype, Clinical Pharmacology & Therapeutics, vol.82,(1),2007,pp 33-40
2002The importance of tumor glucuronidase in the activation of irinotecan in a mouse xenograft modelDodds, Helen; Rivory, Laurent; Tobin, Peter; Cheshire, Pam; Hanna, Suzan; Houghton, Peter J.; Stewart, Clinton F; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; School of Medical Sciences: PharmacologyThe importance of tumor glucuronidase in the activation of irinotecan in a mouse xenograft model, Journal of Pharmacology and Experimental Therapeutics, vol.303,(2),2002,pp 649-655
2006The in vitro metabolism of irinotecan (CPT-11) by carboxylesterase and beta-glucuronidase in human colorectal tumours.Clarke, Stephen; Rivory, Laurent; Seale, John; Solomon, Michael; Tobin, Peter; Aulds, Sally; Crawford, Michael; Eyers, Tony; Gallagher, James; Lee, Soon C; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; School of Medical Sciences: Pharmacology; Central Clinical School: Surgery; School of Medical Sciences: PharmacologyThe in vitro metabolism of irinotecan (CPT-11) by carboxylesterase and beta-glucuronidase in human colorectal tumours., British Journal of Clinical Pharmacology, vol.62,(1),2006,pp 122-129
2003Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapyCharles (nee Slaviero), Kellie; Clarke, Stephen; Rivory, Laurent; School of Medical Sciences: Pharmacology; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineInflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy, Lancet Oncology, vol.4,(4),2003,pp 224-232
2004Inhibition of acetylcholinesterase in patients receiving irinotecan (camptothecin-11)Clarke, Stephen; Rivory, Laurent; Tobin, Peter; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; School of Medical Sciences: PharmacologyInhibition of acetylcholinesterase in patients receiving irinotecan (camptothecin-11), Clinical Pharmacology & Therapeutics, vol.76,(5),2004,pp 505-506
2007Inhibition of topoisomerase I cleavage activity by thiol-reactive compounds: importance of vicinal cysteines 504 and 505Rivory, Laurent; Bjornsti, Mary-Ann; Douat-Casassus, Celine; Montaudon, Daniele; Palle, Komaraiah; Pourquier, Philippe; Quideau, Stephane; Robert, Jacques; Central Clinical School: MedicineInhibition of topoisomerase I cleavage activity by thiol-reactive compounds: importance of vicinal cysteines 504 and 505, Journal of Biological Chemistry, vol.282,(19),2007,pp 14403-14412
2005Loperamide inhibits the biliary excretion of irinotecan (CPT-11) in the rat isolated perfused liverHong, Ying; McLachlan, Andrew; Rivory, Laurent; Seale, John; Tobin, Peter; Pharmacy; Pharmacy; Central Clinical School: Medicine; School of Medical Sciences: Pharmacology; School of Medical Sciences: PharmacologyLoperamide inhibits the biliary excretion of irinotecan (CPT-11) in the rat isolated perfused liver, Journal of pharmacy and pharmacology, vol.57,(N/A),2005,pp 39-45
2007Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedulesClarke, Stephen; Li, Kong; Rivory, Laurent; Concord Clinical School: ANZAC Research Institute; School of Medical Sciences: Pharmacology; Central Clinical School: MedicinePemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules, British Journal of Cancer, vol.97,(8),2007,pp 1071-1076
2002Pemetrexed: single-agent and combination phase 1 study overviewBoyer, Michael; Clarke, Sarah; Rivory, Laurent; Central Clinical School: Medicine; SCA Academic Programs; Central Clinical School: MedicinePemetrexed: single-agent and combination phase 1 study overview, Seminars in Oncology, vol.29,(6 - Supplement 18),2002,pp 18-23
2006A phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancer.Beale, Philip; Clarke, Stephen; Horvath, Lisa; Ong, S; Rivory, Laurent; Sharma, Raghwa; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; MedicineA phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancer., British Journal of Cancer, vol.94,(7),2006,pp 964-968
2006A pilot study on the safety of combining chrysin, a non-absorbable inducer of UGT1A1, and irinotecan (CPT-11) to treat metastatic colorectal cancer.Beale, Philip; Clarke, Stephen; Liddell, Sandy; Noney, Lisa; Rivory, Laurent; Tobin, Peter; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; School of Medical Sciences: Pharmacology; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; School of Medical Sciences: PharmacologyA pilot study on the safety of combining chrysin, a non-absorbable inducer of UGT1A1, and irinotecan (CPT-11) to treat metastatic colorectal cancer., Cancer Chemotherapy and Pharmacology, vol.57,(3),2006,pp 309-316
2004Population Pharmacokinetics Of Raltitrexed In Patients With Advanced Solid Tumours.Blair, Elaine; McLachlan, Andrew; Rivory, Laurent; Clarke, Stephen J.; Pharmacy; Pharmacy; Central Clinical School: MedicinePopulation Pharmacokinetics Of Raltitrexed In Patients With Advanced Solid Tumours., British Journal of Clinical Pharmacology, vol.57,(4),2004,pp 416-426